APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost for Open-angle Glaucoma

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Latanoprost for Open-angle Glaucoma Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchLatanoprost for Open-angle Glaucoma Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost for Open-angle Glaucoma Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Latanoprost for Open-angle Glaucoma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost for Open-angle Glaucoma Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost for Open-angle Glaucoma Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Latanoprost for Open-angle Glaucoma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Latanoprost for Open-angle Glaucoma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Latanoprost for Open-angle Glaucoma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Latanoprost for Open-angle Glaucoma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Latanoprost for Open-angle Glaucoma market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Latanoprost for Open-angle Glaucoma market include CR Zizhu, Novartis, Mylan, China Medical System Holdings, Pfizer, Jiangsu Hengrui Pharmaceuticals, Teva, Taj Pharma and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Latanoprost for Open-angle Glaucoma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Latanoprost for Open-angle Glaucoma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Latanoprost for Open-angle Glaucoma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Latanoprost for Open-angle Glaucoma market size, projected growth trends, production technologies, key applications, and end-use industries.

Latanoprost for Open-angle Glaucoma Segment by Company

CR Zizhu

Novartis

Mylan

China Medical System Holdings

Pfizer

Jiangsu Hengrui Pharmaceuticals

Teva

Taj Pharma

Apotex

Latanoprost for Open-angle Glaucoma Segment by Type

Brand Drug

Generic Drug

Latanoprost for Open-angle Glaucoma Segment by Application

Male Patients

Female Patients

Latanoprost for Open-angle Glaucoma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Latanoprost for Open-angle Glaucoma status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Latanoprost for Open-angle Glaucoma market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Latanoprost for Open-angle Glaucoma significant trends, drivers, influence factors in global and regions.

6. To analyze Latanoprost for Open-angle Glaucoma competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost for Open-angle Glaucoma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost for Open-angle Glaucoma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost for Open-angle Glaucoma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Latanoprost for Open-angle Glaucoma market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Latanoprost for Open-angle Glaucoma industry.

Chapter 3: Detailed analysis of Latanoprost for Open-angle Glaucoma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Latanoprost for Open-angle Glaucoma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Latanoprost for Open-angle Glaucoma in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Latanoprost for Open-angle Glaucoma Industry Trends Table 2. Latanoprost for Open-angle Glaucoma Industry Drivers Table 3. Latanoprost for Open-angle Glaucoma Industry Opportunities and Challenges Table 4. Latanoprost for Open-angle Glaucoma Industry Restraints Table 5. Global Latanoprost for Open-angle Glaucoma Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Latanoprost for Open-angle Glaucoma Revenue Share by Company (2021-2026) Table 7. Global Latanoprost for Open-angle Glaucoma Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Company (2021-2026) Table 9. Global Latanoprost for Open-angle Glaucoma Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Latanoprost for Open-angle Glaucoma Company Ranking, (2024-2026) & (USD Million) Table 11. Global Latanoprost for Open-angle Glaucoma Key Company Manufacturing Base & Headquarters Table 12. Global Latanoprost for Open-angle Glaucoma Company, Product Type & Application Table 13. Global Latanoprost for Open-angle Glaucoma Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Latanoprost for Open-angle Glaucoma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brand Drug Table 18. Significant Companies of Generic Drug Table 19. Global Latanoprost for Open-angle Glaucoma Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Latanoprost for Open-angle Glaucoma Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Latanoprost for Open-angle Glaucoma Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Type (2021-2026) Table 23. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Type (2027-2032) Table 24. Global Latanoprost for Open-angle Glaucoma Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Latanoprost for Open-angle Glaucoma Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Latanoprost for Open-angle Glaucoma Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Type (2021-2026) Table 28. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Male Patients Table 30. Significant Companies of Female Patients Table 31. Global Latanoprost for Open-angle Glaucoma Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Latanoprost for Open-angle Glaucoma Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Latanoprost for Open-angle Glaucoma Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Application (2021-2026) Table 35. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Application (2027-2032) Table 36. Global Latanoprost for Open-angle Glaucoma Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Latanoprost for Open-angle Glaucoma Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Latanoprost for Open-angle Glaucoma Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Application (2021-2026) Table 40. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Application (2027-2032) Table 41. Global Latanoprost for Open-angle Glaucoma Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Latanoprost for Open-angle Glaucoma Sales by Region (2021-2026) & (K Units) Table 43. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Region (2021-2026) Table 44. Global Latanoprost for Open-angle Glaucoma Sales by Region (2027-2032) & (K Units) Table 45. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Region (2027-2032) Table 46. Global Latanoprost for Open-angle Glaucoma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Latanoprost for Open-angle Glaucoma Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Region (2021-2026) Table 49. Global Latanoprost for Open-angle Glaucoma Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Region (2027-2032) Table 51. Global Latanoprost for Open-angle Glaucoma Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Latanoprost for Open-angle Glaucoma Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Latanoprost for Open-angle Glaucoma Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Latanoprost for Open-angle Glaucoma Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Latanoprost for Open-angle Glaucoma Sales by Country (2021-2026) & (K Units) Table 56. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Country (2021-2026) Table 57. Global Latanoprost for Open-angle Glaucoma Sales by Country (2027-2032) & (K Units) Table 58. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Country (2027-2032) Table 59. Global Latanoprost for Open-angle Glaucoma Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Latanoprost for Open-angle Glaucoma Sales Value Market Share by Country (2021-2026) Table 61. Global Latanoprost for Open-angle Glaucoma Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Latanoprost for Open-angle Glaucoma Sales Value Market Share by Country (2027-2032) Table 63. CR Zizhu Company Information Table 64. CR Zizhu Business Overview Table 65. CR Zizhu Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CR Zizhu Latanoprost for Open-angle Glaucoma Product Portfolio Table 67. CR Zizhu Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis Latanoprost for Open-angle Glaucoma Product Portfolio Table 72. Novartis Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mylan Latanoprost for Open-angle Glaucoma Product Portfolio Table 77. Mylan Recent Development Table 78. China Medical System Holdings Company Information Table 79. China Medical System Holdings Business Overview Table 80. China Medical System Holdings Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. China Medical System Holdings Latanoprost for Open-angle Glaucoma Product Portfolio Table 82. China Medical System Holdings Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Latanoprost for Open-angle Glaucoma Product Portfolio Table 87. Pfizer Recent Development Table 88. Jiangsu Hengrui Pharmaceuticals Company Information Table 89. Jiangsu Hengrui Pharmaceuticals Business Overview Table 90. Jiangsu Hengrui Pharmaceuticals Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Pharmaceuticals Latanoprost for Open-angle Glaucoma Product Portfolio Table 92. Jiangsu Hengrui Pharmaceuticals Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Teva Latanoprost for Open-angle Glaucoma Product Portfolio Table 97. Teva Recent Development Table 98. Taj Pharma Company Information Table 99. Taj Pharma Business Overview Table 100. Taj Pharma Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Taj Pharma Latanoprost for Open-angle Glaucoma Product Portfolio Table 102. Taj Pharma Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Latanoprost for Open-angle Glaucoma Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Apotex Latanoprost for Open-angle Glaucoma Product Portfolio Table 107. Apotex Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Latanoprost for Open-angle Glaucoma Distributors List Table 111. Latanoprost for Open-angle Glaucoma Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Latanoprost for Open-angle Glaucoma Product Image Figure 2. Global Latanoprost for Open-angle Glaucoma Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 4. Global Latanoprost for Open-angle Glaucoma Sales (2021-2032) & (K Units) Figure 5. Global Latanoprost for Open-angle Glaucoma Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Latanoprost for Open-angle Glaucoma Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brand Drug Image Figure 10. Generic Drug Image Figure 11. Global Latanoprost for Open-angle Glaucoma Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Latanoprost for Open-angle Glaucoma Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Type (2021-2032) Figure 14. Global Latanoprost for Open-angle Glaucoma Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Latanoprost for Open-angle Glaucoma Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Type (2021-2032) Figure 17. Male Patients Image Figure 18. Female Patients Image Figure 19. Global Latanoprost for Open-angle Glaucoma Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Latanoprost for Open-angle Glaucoma Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Application (2021-2032) Figure 22. Global Latanoprost for Open-angle Glaucoma Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Latanoprost for Open-angle Glaucoma Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Application (2021-2032) Figure 25. Global Latanoprost for Open-angle Glaucoma Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Latanoprost for Open-angle Glaucoma Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Latanoprost for Open-angle Glaucoma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Latanoprost for Open-angle Glaucoma Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 30. North America Latanoprost for Open-angle Glaucoma Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Latanoprost for Open-angle Glaucoma Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 36. South America Latanoprost for Open-angle Glaucoma Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Latanoprost for Open-angle Glaucoma Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Latanoprost for Open-angle Glaucoma Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Male Patients
  • Female Patients
Companies covered
  • CR Zizhu
  • Novartis
  • Mylan
  • China Medical System Holdings
  • Pfizer
  • Jiangsu Hengrui Pharmaceuticals
  • Teva
  • Taj Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  4. 1.2.2 Global Latanoprost for Open-angle Glaucoma Sales Volume (2021-2032)
  5. 1.2.3 Global Latanoprost for Open-angle Glaucoma Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Latanoprost for Open-angle Glaucoma Market Dynamics
  1. 2.1 Latanoprost for Open-angle Glaucoma Industry Trends
  2. 2.2 Latanoprost for Open-angle Glaucoma Industry Drivers
  3. 2.3 Latanoprost for Open-angle Glaucoma Industry Opportunities and Challenges
  4. 2.4 Latanoprost for Open-angle Glaucoma Industry Restraints
3 Latanoprost for Open-angle Glaucoma Market by Company
  1. 3.1 Global Latanoprost for Open-angle Glaucoma Company Revenue Ranking in 2025
  2. 3.2 Global Latanoprost for Open-angle Glaucoma Revenue by Company (2021-2026)
  3. 3.3 Global Latanoprost for Open-angle Glaucoma Sales Volume by Company (2021-2026)
  4. 3.4 Global Latanoprost for Open-angle Glaucoma Average Price by Company (2021-2026)
  5. 3.5 Global Latanoprost for Open-angle Glaucoma Company Ranking (2024-2026)
  6. 3.6 Global Latanoprost for Open-angle Glaucoma Company Manufacturing Base and Headquarters
  7. 3.7 Global Latanoprost for Open-angle Glaucoma Company Product Type and Application
  8. 3.8 Global Latanoprost for Open-angle Glaucoma Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Latanoprost for Open-angle Glaucoma Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Latanoprost for Open-angle Glaucoma Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Latanoprost for Open-angle Glaucoma Market by Type
  1. 4.1 Latanoprost for Open-angle Glaucoma Type Introduction
  2. 4.1.1 Brand Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Latanoprost for Open-angle Glaucoma Sales Volume by Type
  5. 4.2.1 Global Latanoprost for Open-angle Glaucoma Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Latanoprost for Open-angle Glaucoma Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Latanoprost for Open-angle Glaucoma Sales Value by Type
  9. 4.3.1 Global Latanoprost for Open-angle Glaucoma Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Latanoprost for Open-angle Glaucoma Sales Value by Type (2021-2032)
  11. 4.3.3 Global Latanoprost for Open-angle Glaucoma Sales Value Share by Type (2021-2032)
5 Latanoprost for Open-angle Glaucoma Market by Application
  1. 5.1 Latanoprost for Open-angle Glaucoma Application Introduction
  2. 5.1.1 Male Patients
  3. 5.1.2 Female Patients
  4. 5.2 Global Latanoprost for Open-angle Glaucoma Sales Volume by Application
  5. 5.2.1 Global Latanoprost for Open-angle Glaucoma Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Latanoprost for Open-angle Glaucoma Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Latanoprost for Open-angle Glaucoma Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Latanoprost for Open-angle Glaucoma Sales Value by Application
  9. 5.3.1 Global Latanoprost for Open-angle Glaucoma Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Latanoprost for Open-angle Glaucoma Sales Value by Application (2021-2032)
  11. 5.3.3 Global Latanoprost for Open-angle Glaucoma Sales Value Share by Application (2021-2032)
6 Latanoprost for Open-angle Glaucoma Regional Sales and Value Analysis
  1. 6.1 Global Latanoprost for Open-angle Glaucoma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Latanoprost for Open-angle Glaucoma Sales by Region (2021-2032)
  3. 6.2.1 Global Latanoprost for Open-angle Glaucoma Sales by Region: 2021-2026
  4. 6.2.2 Global Latanoprost for Open-angle Glaucoma Sales by Region (2027-2032)
  5. 6.3 Global Latanoprost for Open-angle Glaucoma Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Latanoprost for Open-angle Glaucoma Sales Value by Region (2021-2032)
  7. 6.4.1 Global Latanoprost for Open-angle Glaucoma Sales Value by Region: 2021-2026
  8. 6.4.2 Global Latanoprost for Open-angle Glaucoma Sales Value by Region (2027-2032)
  9. 6.5 Global Latanoprost for Open-angle Glaucoma Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  12. 6.6.2 North America Latanoprost for Open-angle Glaucoma Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  15. 6.7.2 Europe Latanoprost for Open-angle Glaucoma Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Latanoprost for Open-angle Glaucoma Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  21. 6.9.2 South America Latanoprost for Open-angle Glaucoma Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Latanoprost for Open-angle Glaucoma Sales Value Share by Country, 2025 VS 2032
7 Latanoprost for Open-angle Glaucoma Country-level Sales and Value Analysis
  1. 7.1 Global Latanoprost for Open-angle Glaucoma Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Latanoprost for Open-angle Glaucoma Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Latanoprost for Open-angle Glaucoma Sales by Country (2021-2032)
  4. 7.3.1 Global Latanoprost for Open-angle Glaucoma Sales by Country (2021-2026)
  5. 7.3.2 Global Latanoprost for Open-angle Glaucoma Sales by Country (2027-2032)
  6. 7.4 Global Latanoprost for Open-angle Glaucoma Sales Value by Country (2021-2032)
  7. 7.4.1 Global Latanoprost for Open-angle Glaucoma Sales Value by Country (2021-2026)
  8. 7.4.2 Global Latanoprost for Open-angle Glaucoma Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Latanoprost for Open-angle Glaucoma Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Latanoprost for Open-angle Glaucoma Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Latanoprost for Open-angle Glaucoma Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CR Zizhu
  2. 8.1.1 CR Zizhu Company Information
  3. 8.1.2 CR Zizhu Business Overview
  4. 8.1.3 CR Zizhu Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CR Zizhu Latanoprost for Open-angle Glaucoma Product Portfolio
  6. 8.1.5 CR Zizhu Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Latanoprost for Open-angle Glaucoma Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Latanoprost for Open-angle Glaucoma Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 China Medical System Holdings
  20. 8.4.1 China Medical System Holdings Company Information
  21. 8.4.2 China Medical System Holdings Business Overview
  22. 8.4.3 China Medical System Holdings Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 China Medical System Holdings Latanoprost for Open-angle Glaucoma Product Portfolio
  24. 8.4.5 China Medical System Holdings Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Latanoprost for Open-angle Glaucoma Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Jiangsu Hengrui Pharmaceuticals
  32. 8.6.1 Jiangsu Hengrui Pharmaceuticals Company Information
  33. 8.6.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  34. 8.6.3 Jiangsu Hengrui Pharmaceuticals Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Pharmaceuticals Latanoprost for Open-angle Glaucoma Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  37. 8.7 Teva
  38. 8.7.1 Teva Company Information
  39. 8.7.2 Teva Business Overview
  40. 8.7.3 Teva Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Teva Latanoprost for Open-angle Glaucoma Product Portfolio
  42. 8.7.5 Teva Recent Developments
  43. 8.8 Taj Pharma
  44. 8.8.1 Taj Pharma Company Information
  45. 8.8.2 Taj Pharma Business Overview
  46. 8.8.3 Taj Pharma Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Taj Pharma Latanoprost for Open-angle Glaucoma Product Portfolio
  48. 8.8.5 Taj Pharma Recent Developments
  49. 8.9 Apotex
  50. 8.9.1 Apotex Company Information
  51. 8.9.2 Apotex Business Overview
  52. 8.9.3 Apotex Latanoprost for Open-angle Glaucoma Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Apotex Latanoprost for Open-angle Glaucoma Product Portfolio
  54. 8.9.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Latanoprost for Open-angle Glaucoma Value Chain Analysis
  2. 9.1.1 Latanoprost for Open-angle Glaucoma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Latanoprost for Open-angle Glaucoma Sales Mode & Process
  6. 9.2 Latanoprost for Open-angle Glaucoma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Latanoprost for Open-angle Glaucoma Distributors
  9. 9.2.3 Latanoprost for Open-angle Glaucoma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst